Independent · non-commercial · publishes on a quarterly cycle|Current cycle 2026 Q3
Compound Evidence InstituteEvidence synthesis · established 2023Graded assessments of compounds, trials, methods and supply
Document set current to 30 July 2026
Consultation record

Submissions accepted — page 7

The submission is accepted and the draft is amended as proposed. The amendment is recorded in the amendment log of the document it changed and is traceable to the numbered submission.

Submissions

735 documents · page 7 of 25

Table 1. Submissions with this disposition, on this page.

ReferenceConsultationRespondentPoint raised
DRAFT-ADOLESCENT-S/005Draft synthesis: incretin receptor agonists in adolescentsDr Evander Ashworth-DanquahThe same concept is given three different names in one document
DRAFT-ADOLESCENT-S/006Draft synthesis: incretin receptor agonists in adolescentsEamon Sandringham-AduThe search strategy as published cannot be re-run
DRAFT-ADOLESCENT-S/007Draft synthesis: incretin receptor agonists in adolescentsDr Delphine TrelawneyThe comparator was given at a dose below the one in general use
DRAFT-ADOLESCENT-S/008Draft synthesis: incretin receptor agonists in adolescentsDr Ivo QuintanilhaAttrition is assessed in the risk-of-bias domains and not reported as a number
DRAFT-ADOLESCENT-S/010Draft synthesis: incretin receptor agonists in adolescentsStellan Cholmondeley-AdeThe review does not say when it will be updated or what would trigger an update
DRAFT-ADOLESCENT-S/013Draft synthesis: incretin receptor agonists in adolescentsDr Jozef Brandvold-AchterbergRisk-of-bias judgements are reported as an overall rating without the domains
DRAFT-ADOLESCENT-S/015Draft synthesis: incretin receptor agonists in adolescentsDr Matthias Wintringham industryTwo factual descriptions of the sponsor's programme are inaccurate
DRAFT-ANALYTICAL-S/002Draft analytical review: surveys of unregulated peptide supplyDr Quentin ZimmerthalThe draft moves between purity and content as though they were one quantity
DRAFT-ANALYTICAL-S/003Draft analytical review: surveys of unregulated peptide supplyDr Melisande Thorsby-NakamuraIndependent results are not paired with the certificate figure for the same lot
DRAFT-ANALYTICAL-S/004Draft analytical review: surveys of unregulated peptide supplyDr Eamon ImmelmannQuantitative claims are reproduced without the method that produced them
DRAFT-ANALYTICAL-S/006Draft analytical review: surveys of unregulated peptide supplyDr Jolanta UttridgeContributing results are reported in units that were not converted before pooling
DRAFT-ANALYTICAL-S/010Draft analytical review: surveys of unregulated peptide supplyDr Sigrún VercingetorixResults below the limit of quantitation are treated as zero
DRAFT-ANALYTICAL-S/011Draft analytical review: surveys of unregulated peptide supplyDr Kamila Glendinning-UcheContent results are reported without the standard they were assigned against
DRAFT-ANALYTICAL-S/014Draft analytical review: surveys of unregulated peptide supplyDr Yusuf Whitmarsh-ObiOne laboratory contributes most of the results in the pooled set
DRAFT-REGISTRY-STR/002Draft structure of the document registryAnselm MountstephenThe registry is published only as pages and not in a form that can be processed
DRAFT-REGISTRY-STR/004Draft structure of the document registryDr Adaeze Underhill-OkaforFour dates are given and their relation is not explained
DRAFT-REGISTRY-STR/005Draft structure of the document registryDr Rosalind PetrossianA printed copy loses the document identifier
DRAFT-REGISTRY-STR/006Draft structure of the document registryStellan Cholmondeley-AdeThe same quantity is presented differently in two series
DRAFT-REGISTRY-STR/007Draft structure of the document registryEamon Sandringham-AduThe front-matter summary describes the finding without stating it
DRAFT-REGISTRY-STR/009Draft structure of the document registryDr Ivo QuintanilhaA document does not show what draws on it
DRAFT-TOOLS-DISCLA/001Draft terms for the Institute’s calculatorsProfessor Bartolomeu Nkosi-LindegaardIndependence is asserted and the mechanism securing it is not described
DRAFT-TOOLS-DISCLA/002Draft terms for the Institute’s calculatorsDr Georgiana MountstephenWhat the site collects about a reader is not stated in terms a reader can check
DRAFT-TOOLS-DISCLA/003Draft terms for the Institute’s calculatorsEamon Sandringham-AduThe search date is not on the face of the document
DRAFT-TOOLS-DISCLA/004Draft terms for the Institute’s calculatorsDr Vasilisa Sandringham-AduA party that is assessed and also sponsors should be disclosed on its own assessment
DRAFT-TOOLS-DISCLA/005Draft terms for the Institute’s calculatorsIvo MountstephenThe terms on which the documents may be reused are not stated
DRAFT-TOOLS-DISCLA/008Draft terms for the Institute’s calculatorsDr Quentin EnthovenNo term limit applies to membership of the assessment committee
DRAFT-TOOLS-DISCLA/009Draft terms for the Institute’s calculatorsAnselm MountstephenA reader who acted on a document is not told when it is corrected
DRAFT-TOOLS-DISCLA/013Draft terms for the Institute’s calculatorsDr Evander Ashworth-DanquahThe same concept is given three different names in one document
DRAFT-TOOLS-DISCLA/015Draft terms for the Institute’s calculatorsDr Quentin Gwynne-SarpongWhether external reviewers are paid is not stated
DRAFT-TOOLS-DISCLA/016Draft terms for the Institute’s calculatorsDr Vasilisa ImmelmannThere is no route to challenge a disposition

page 7 of 25

Nothing published by the Institute is medical advice, a diagnosis, a prescription, a treatment recommendation or a purchasing recommendation. Compounds supplied for research use are not approved for human or veterinary use in any jurisdiction, and a favourable analytical assessment of a supplier is not a statement that any product is safe or effective. The Institute publishes certainty ratings and never recommendations. No telephone number, messaging handle or ordering channel appears anywhere on this site.